Biolife Solutions Inc’s recently made public that its Chief Human Resources Officer Aebersold Sarah unloaded Company’s shares for reported $0.13 million on Apr 01 ’25. In the deal valued at $22.66 per share,5,771 shares were sold. As a result of this transaction, Aebersold Sarah now holds 80,094 shares worth roughly $1.67 million.
Then, Berard Todd sold 8,902 shares, generating $201,719 in total proceeds. Upon selling the shares at $22.66, the Chief Marketing Officer now owns 135,956 shares.
Before that, Wichterman Troy sold 25,687 shares. Biolife Solutions Inc shares valued at $582,067 were divested by the Chief Financial Officer at a price of $22.66 per share. As a result of the transaction, Wichterman Troy now holds 189,242 shares, worth roughly $3.95 million.
H.C. Wainwright initiated its Biolife Solutions Inc [BLFS] rating to a Buy in a research note published on September 30, 2024; the price target was $29. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in early April with a ‘”a Buy”‘ rating. Craig Hallum began covering BLFS with “Buy” recommendation on July 11, 2023. Oppenheimer revised its rating on April 25, 2022. It rated BLFS as “an Outperform” which previously was an “a Perform”.
Price Performance Review of BLFS
On Friday, Biolife Solutions Inc [NASDAQ:BLFS] saw its stock fall -6.95% to $20.88. Over the last five days, the stock has lost -19.57%. Biolife Solutions Inc shares have fallen nearly -19.57% since the year began. Nevertheless, the stocks have risen 20.55% over the past one year. While a 52-week high of $29.55 was reached on 01/30/25, a 52-week low of $14.84 was recorded on 04/04/25. SMA at 50 days reached $25.87, while 200 days put it at $24.71.
Levels Of Support And Resistance For BLFS Stock
The 24-hour chart illustrates a support level at 19.86, which if violated will result in even more drops to 18.84. On the upside, there is a resistance level at 22.10. A further resistance level may holdings at 23.32. The Relative Strength Index (RSI) on the 14-day chart is 32.20, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.17, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 87.33%. Stochastics %K at 21.99% indicates the stock is a holding.
How much short interest is there in Biolife Solutions Inc?
A steep rise in short interest was recorded in Biolife Solutions Inc stocks on 2025-03-14, growing by 92229.0 shares to a total of 3.47 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 3.37 million shares. There was a rise of 2.66%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on October 19, 2021 when B. Riley Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $61 price target.
